714

540797

SHALBY

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SHALBY LIMITED Share Price Today

SHALBY LIMITED is currently trading at ₹171.9, up by ₹0.28 from the previous close. The stock touched an intraday high of ₹173.43 and a low of ₹171.01 during the latest trading session. Over the past one year, SHALBY LIMITED has delivered a loss of 6.26%, while the stock has gained 6.95% in the last one month.

SHALBY LIMITED performance

Today’s low Today’s high
₹ 171.01 ₹ 173.43
₹ 171.61
52 week low 52 week high
₹ 125.82 ₹ 274.70
₹ 171.61
Open Price ₹ 172.25
Prev. Close ₹ 171.61
Volume (Shares) 76097.00
Total traded value ₹ 130.59
Upper Circuit ₹ 205.93
Lower Circuit ₹ 137.29
info

Investment Returns

Over 1 Month 6.95% Over 3 Months 21.57% Over 6 Months -11.79% Over 1 Year -6.26%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SHALBY LIMITED fundamentals


  • Market cap (Cr) 1,853.60
  • P/E Ratio (TTM) 16.34
  • Beta 1.40
  • Book Value / share 115.49
  • Return on equity 7.63%
  • EPS (TTM) 10.49
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 53.67
info icon alternate text
  • Market cap (Cr) 1,858.80
  • P/E Ratio (TTM) 16.34
  • Beta 1.30
  • Book Value / share 115.49
  • Return on equity 7.63%
  • EPS (TTM) 10.49
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 53.67
info icon alternate text

SHALBY LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 224.85
Operating Expense 206.29
Net Profit 53.67
Net Profit Margin (%) 23.86
Earnings Per Share (EPS) 4.99
EBITDA 36.35
Effective Tax Rate (%) -128.77
Particulars DEC 2025 (Values in Cr)
Revenue 213.51
Operating Expense 199.14
Net Profit 13.79
Net Profit Margin (%) 6.45
Earnings Per Share (EPS) 1.28
EBITDA 35.42
Effective Tax Rate (%) 36.94
Particulars SEP 2025 (Values in Cr)
Revenue 223.97
Operating Expense 199.21
Net Profit 19.75
Net Profit Margin (%) 8.81
Earnings Per Share (EPS) 1.84
EBITDA 44.77
Effective Tax Rate (%) 35.37
Particulars JUN 2025 (Values in Cr)
Revenue 236.65
Operating Expense 202.07
Net Profit 25.70
Net Profit Margin (%) 10.85
Earnings Per Share (EPS) 2.39
EBITDA 52.36
Effective Tax Rate (%) 35.93
Particulars MAR 2025 (Values in Cr)
Revenue 207.00
Operating Expense 188.52
Net Profit 14.96
Net Profit Margin (%) 7.22
Earnings Per Share (EPS) 1.39
EBITDA 37.97
Effective Tax Rate (%) 41.74
Particulars MAR 2026 (Values in Cr)
Revenue 898.56
Operating Expense 806.73
Net Profit 112.91
Net Profit Margin (%) 12.56
Earnings Per Share (EPS) 10.50
EBITDA 168.93
Effective Tax Rate (%) 2.66
Particulars MAR 2025 (Values in Cr)
Revenue 868.86
Operating Expense 763.38
Net Profit 83.79
Net Profit Margin (%) 9.64
Earnings Per Share (EPS) 7.80
EBITDA 185.74
Effective Tax Rate (%) 38.27
Particulars MAR 2024 (Values in Cr)
Revenue 829.68
Operating Expense 692.08
Net Profit 103.85
Net Profit Margin (%) 12.51
Earnings Per Share (EPS) 9.67
EBITDA 198.27
Effective Tax Rate (%) 34.40
Particulars MAR 2023 (Values in Cr)
Revenue 708.02
Operating Expense 606.03
Net Profit 80.81
Net Profit Margin (%) 11.41
Earnings Per Share (EPS) 7.52
EBITDA 161.51
Effective Tax Rate (%) 33.41
Particulars MAR 2022 (Values in Cr)
Revenue 646.80
Operating Expense 555.43
Net Profit 69.81
Net Profit Margin (%) 10.79
Earnings Per Share (EPS) 6.46
EBITDA 138.21
Effective Tax Rate (%) 30.13
Particulars MAR 2025 (Values in Cr)
Book Value / Share 92.31
ROE % 0.19
ROCE % 6.08
Total Debt to Total Equity 0.43
EBITDA Margin 14.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 93.13
ROE % 8.66
ROCE % 11.59
Total Debt to Total Equity 0.29
EBITDA Margin 21.21
Particulars MAR 2023 (Values in Cr)
Book Value / Share 86.45
ROE % 7.50
ROCE % 10.33
Total Debt to Total Equity 0.19
EBITDA Margin 19.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 81.13
ROE % 6.31
ROCE % 8.85
Total Debt to Total Equity 0.12
EBITDA Margin 18.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 77.28
ROE % 5.19
ROCE % 6.70
Total Debt to Total Equity 0.07
EBITDA Margin 22.37
Particulars MAR 2025 (Values in Cr)
Book Value / Share 105.50
ROE % 7.63
ROCE % 12.11
Total Debt to Total Equity 0.11
EBITDA Margin 21.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 98.89
ROE % 10.22
ROCE % 14.70
Total Debt to Total Equity 0.08
EBITDA Margin 24.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.42
ROE % 8.61
ROCE % 12.67
Total Debt to Total Equity 0.04
EBITDA Margin 23.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 83.95
ROE % 7.95
ROCE % 11.07
Total Debt to Total Equity 0.05
EBITDA Margin 21.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.66
ROE % 5.16
ROCE % 6.63
Total Debt to Total Equity 0.06
EBITDA Margin 23.09
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 34.86
Total Assets 1703.65
Total Liabilities 1703.65
Total Equity 995.32
Share Outstanding 10
Price to Book Ratio 1.88
Return on Assets (%) 0.36
Return on Capital (%) 0.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 27.22
Total Assets 1607.53
Total Liabilities 1607.53
Total Equity 1007.78
Share Outstanding 10
Price to Book Ratio 2.42
Return on Assets (%) 5.23
Return on Capital (%) 6.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.28
Total Assets 1281.36
Total Liabilities 1281.36
Total Equity 927.61
Share Outstanding 10
Price to Book Ratio 1.49
Return on Assets (%) 5.28
Return on Capital (%) 6.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 110.56
Total Assets 1193.53
Total Liabilities 1193.53
Total Equity 876.18
Share Outstanding 10
Price to Book Ratio 1.39
Return on Assets (%) 4.53
Return on Capital (%) 5.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 83.57
Total Assets 996.62
Total Liabilities 996.62
Total Equity 834.67
Share Outstanding 10
Price to Book Ratio 1.28
Return on Assets (%) 4.25
Return on Capital (%) 4.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 21.65
Total Assets 1469.80
Total Liabilities 1469.80
Total Equity 1133.99
Share Outstanding 10
Price to Book Ratio 1.88
Return on Assets (%) 5.70
Return on Capital (%) 6.77
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.22
Total Assets 1373.98
Total Liabilities 1373.98
Total Equity 1062.17
Share Outstanding 10
Price to Book Ratio 2.42
Return on Assets (%) 7.55
Return on Capital (%) 8.83
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.32
Total Assets 1165.65
Total Liabilities 1165.65
Total Equity 970.32
Share Outstanding 10
Price to Book Ratio 1.49
Return on Assets (%) 6.93
Return on Capital (%) 8.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 104.39
Total Assets 1087.38
Total Liabilities 1087.38
Total Equity 906.72
Share Outstanding 10
Price to Book Ratio 1.39
Return on Assets (%) 6.41
Return on Capital (%) 7.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 82.96
Total Assets 1012.25
Total Liabilities 1012.25
Total Equity 849.64
Share Outstanding 10
Price to Book Ratio 1.28
Return on Assets (%) 4.23
Return on Capital (%) 4.8
Particulars MAR 2025 (Values in Cr)
Net Income 55.72
Cash from Operations 9.89
Cash from Investing -35.63
Cash from Financing 47.58
Net change in Cash 7.60
Free Cash Flow 81.34
Particulars MAR 2024 (Values in Cr)
Net Income 128.19
Cash from Operations 39.66
Cash from Investing 38.07
Cash from Financing -150.69
Net change in Cash -93.02
Free Cash Flow 86.76
Particulars MAR 2023 (Values in Cr)
Net Income 102.04
Cash from Operations 96.18
Cash from Investing -61.07
Cash from Financing -50.00
Net change in Cash -43.30
Free Cash Flow 114.66
Particulars MAR 2022 (Values in Cr)
Net Income 79.14
Cash from Operations 41.90
Cash from Investing -60.30
Cash from Financing 90.45
Net change in Cash 49.07
Free Cash Flow 117.29
Particulars MAR 2021 (Values in Cr)
Net Income 55.05
Cash from Operations 88.24
Cash from Investing -51.26
Cash from Financing -29.85
Net change in Cash -1.97
Free Cash Flow 109.10
Particulars MAR 2025 (Values in Cr)
Net Income 135.74
Cash from Operations 160.23
Cash from Investing -100.62
Cash from Financing -35.79
Net change in Cash 12.39
Free Cash Flow 183.32
Particulars MAR 2024 (Values in Cr)
Net Income 158.31
Cash from Operations 159.53
Cash from Investing -206.00
Cash from Financing 72.13
Net change in Cash 5.90
Free Cash Flow 190.80
Particulars MAR 2023 (Values in Cr)
Net Income 121.35
Cash from Operations 191.59
Cash from Investing -172.40
Cash from Financing -38.21
Net change in Cash -46.08
Free Cash Flow 195.04
Particulars MAR 2022 (Values in Cr)
Net Income 99.92
Cash from Operations 123.73
Cash from Investing -40.31
Cash from Financing -17.24
Net change in Cash 43.36
Free Cash Flow 158.40
Particulars MAR 2021 (Values in Cr)
Net Income 55.49
Cash from Operations 86.48
Cash from Investing -51.83
Cash from Financing -27.82
Net change in Cash -2.41
Free Cash Flow 107.28
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8389.75 61.67 12.73 120631.73 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.94 23.95 2.89 99.22 40.75 77.00
SHREE PACETRONIX LTD. 138.15 16.49 2.90 51.80 66.10 283.15
TRANSGENE BIOTEK LTD. 3.02 0.00 2.73 22.88 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8389.75 80.35 12.10 120631.73 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 36.30 0.00 -8.83 27.12 30.30 57.48
KOVAI MEDICAL CENTER & HO 5790.65 25.91 4.80 6334.97 5010.00 6725.00

SHALBY LIMITED shareholding pattern

Holding
21.06%
74.32%
4.36%
0.24%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SHALBY LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
171.61 0.71 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 169.50
  • 26 Days 168.00
  • 10 Days 169.70
  • 50 Days 165.30
  • 12 Days 169.70
  • 100 Days 168.20
  • 20 Days 169.00
  • 200 Days 180.60
170.60 PIVOT
First Support 168.42 First Resistance 172.57 Second Support 166.45 Second Resistance 174.75 Third Support 164.27 Third Resistance 176.72
RSI 54.08 ADX 6.65 MACD 1.69 Williams % R -58.65 Commodity Channel Index (CCI) -11.26
Date 2026-06-16 Week 43055.00 Same Day 15199.00 Month 54199.00
1 Year 1.40 3 Year 1.26
Over 1 Month
6.95% down
Over 1 Year
-6.26% down
Over 3 Months
21.57% down
Over 3 Years
3.70% down
Over 6 Months
-11.79% down
Over 5 Years
1.16% down

SHALBY LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2024 1.2 Final 20 Sep 2024 Equity shares
08 Aug 2023 1.2 Final 09 Aug 2023 Equity shares
19 Sep 2022 1.0 Final 21 Sep 2022 Equity shares
17 Sep 2021 1.0 Final 21 Sep 2021 Equity shares
04 Sep 2020 0.5 Final 08 Sep 2020 Equity shares
16 Aug 2019 0.5 Final 20 Aug 2019 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2024 1.2 Final 20 Sep 2024 Equity shares
08 Aug 2023 1.2 Final 09 Aug 2023 Equity shares
19 Sep 2022 1.0 Final 21 Sep 2022 Equity shares
17 Sep 2021 1.0 Final 21 Sep 2021 Equity shares
04 Sep 2020 0.5 Final 08 Sep 2020 Equity shares
16 Aug 2019 0.5 Final 20 Aug 2019 Equity shares

Top Gainers

Top Losers

Shalby Ltd share result highlights

For Q1 of FY 25-26, the company's consolidated sales were ₹296.43 crore, and its net profit for the period stood at ₹7.68 crore. In the corresponding Q1 of FY 24-25, the sales were ₹278.89 crore with a net profit of ₹14.74 crore for the period.

Date Source: screener.in, and corporate filings on NSE/BSE

Shalby Ltd share annual reports

For FY 24-25, the company reported consolidated sales of ₹1,087 crore and a net profit of ₹2 crore. In the preceding year, FY 23-24, the company's sales were ₹934 crore, and the net profit was ₹84 crore.

Date Source: screener.in, and corporate filings on NSE/BSE

Shalby Ltd share dividend

The company's stock has a face value of ₹10.00 per share and pays a dividend yield of 0.52%. The company has not yet declared any dividend for the current financial year, while it had announced a dividend for FY 2024-25 of ₹1.20 per share with ex-date of 19 September, 2024. 

Date Source: screener.in, and corporate filings on NSE/BSE

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shalby Ltd?

Answer Field

Shalby Ltd share price is for NSE ₹ 171.90 & for BSE ₹ 171.95 as on Jun 18 2026 11:27 AM.

What is the Market Cap of Shalby Ltd Share?

Answer Field

The market cap of Shalby Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 18 2026 11:27 AM.

What is the 52 Week High and Low of Shalby Ltd?

Answer Field

The 52 Week High and Low of Shalby Ltd for NSE is ₹ 274.70 and ₹ 125.82 and for BSE is ₹ 274.50 and ₹ 125.70.

What is 1 year return for Shalby Ltd?

Answer Field

The 1 year returns on the stock has been -6.26%.

What is the P/E Ratio of Shalby Ltd Share?

Answer Field

As on Jun 18 2026 11:27 AM the price-to-earnings (PE) ratio for Shalby Ltd share is 16.34.

What is the PB ratio of Shalby Ltd Share?

Answer Field

As on Jun 18 2026 11:27 AM, the price-to-book (PB) ratio for Shalby Ltd share is 115.49.

How to Buy Shalby Ltd Share?

Answer Field

You can trade in Shalby Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shalby Ltd Share on Bajaj Broking App?

Answer Field

To buy Shalby Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shalby Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

Who is the CEO of Shalby?

Answer Field

The CEO of Shalby is responsible for leading the company’s strategic vision and overseeing its healthcare operations. Under their leadership, Shalby has continued to grow and expand its presence in the healthcare industry. The CEO’s focus on enhancing service quality and operational efficiency has contributed to the company’s positive financial performance, which has had a direct influence on the Shalby share price. Investors watch the CEO’s decisions closely to assess the company’s future prospects.

When was Shalby established?

Answer Field

Shalby was established several decades ago, entering the healthcare sector with a focus on providing quality medical services. Since its inception, the company has grown steadily, contributing to the rise in the Shalby share price. Over the years, Shalby has expanded its hospital network and diversified its service offerings, becoming a recognised name in the healthcare industry. The company’s establishment laid the foundation for its current success and continued market presence.

What factors influence the Shalby share price?

Answer Field

Several factors influence the Shalby share price, including the company’s financial performance, patient admissions, and operational efficiency. Internal factors such as revenue growth, profitability, and service expansion also play a critical role. External factors like industry trends, healthcare demand, and government policies further impact the share price. Investors carefully monitor these variables to assess potential movements in the Shalby share price and make informed decisions based on market and company performance.

Is Shalby debt free?

Answer Field

Shalby is not entirely debt-free but maintains a manageable level of debt that supports its growth and expansion plans. The company’s financial reports reflect that its debt levels are well-controlled and do not pose significant risks to its operations. This prudent debt management strategy positively impacts investor confidence and the Shalby share price, as the company continues to maintain financial stability while pursuing growth opportunities in the healthcare sector.

How has the Shalby share price performed over the past year?

Answer Field

The Shalby share price has experienced moderate fluctuations over the past year, influenced by the company’s financial performance and broader market conditions. While the share price saw periods of growth driven by strong earnings and hospital expansions, it also faced some volatility due to external factors. Overall, the Shalby share price has remained stable, reflecting the company’s solid position in the healthcare industry. Investors continue to monitor the company’s performance closely for future growth potential.

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|